Health Blog

A Bright Update on Melanoma Treatment

Posted on: March 28, 2019

By Dr. Jeffrey Zweig Melanoma skin cancer is unfortunately on the rise worldwide, and is now considered the 5th most common cancer diagnosis in the United States. It is estimated that in 2019, there will be over 95,000 new cases of melanoma diagnosed in the US and over 7,000 deaths. Luckily, most patients will be… read more

Harnessing the Immune System to Fight Colon Cancer

Posted on: February 20, 2019

Colorectal cancer is the third most common cancer diagnosed in both men and women in the United States. The American Cancer Society’s estimates that almost 101,420 new cases of colon cancer will be diagnosed in 2019. While chemotherapy is still used to prevent recurrence of early stage colon cancer and treatment of advanced/metastatic colon cancer,… read more

Annual Hematology Conference Outlines New Standard of Care for Chronic Lymphocytic Leukemia

Posted on: December 27, 2018

By Robert Robles, MD The American Society of Hematology Annual Meeting was held in San Diego at the beginning of December, 2018. An international crowd of 28,000 Hematologists and Oncologists were in attendance. The most important development reported concerned treatment for chronic lymphocytic leukemia, the most common leukemia in North America and Western Europe. A… read more

The Many Faces of Breast Cancer – Full seminar recorded

Posted on: November 15, 2018


American Cancer Society honors Dr. Tiffany Svahn

Posted on: October 29, 2018

Breast Cancer Specialist, Dr. Tiffany Svahn is Honored by the American Cancer Society PLEASANT HILL, CA (October 22, 2018) Diablo Valley Oncology and Hematology Medical Group is proud to announce that their lead breast cancer specialist, Tiffany Svahn, MD was honored by the American Cancer Society at their 9th Annual Jewel Ball, which took place… read more

Individualized Treatment Decisions for Breast Cancer

Posted on: June 15, 2018

The long-awaited results from the TailoRx (Trial Assigning Individualized Options for Treatment) trial were released in June at the American Society of Clinical Oncology in Chicago. The results confirm that using the gene expression test (OncotypeDX) to assess the risk of breast cancer recurrence can spare many women unnecessary treatment with chemotherapy that will not… read more